Ahmad Vaez

Dr. Ahmad Vaez

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2020 in Scientific Reports
Verified
Journal Article
Open access
HSHadi Samadian
Hadi Samadian
SZSina Zamiri
Sina Zamiri
AEArian Ehterami
Arian Ehterami
SFSaeed Farzamfar
Saeed Farzamfar
AVAhmad Vaez
Ahmad Vaez
NMNaimeh Mahheidari
Naimeh Mahheidari
Functional wound dressing with tailored physicochemical and biological properties is vital for diabetic foot ulcer (DFU) treatment. Our main objective in the current study was to fabricate Cellulose Acetate/Gelatin (CA/Gel) electrospun mat loaded with berberine (Beri) as the DFU-specific wound dressing. The wound healing efficacy of the fabricated dressings was evaluated in streptozotocin-induced diabetic rats. The results demonstrated an average nanofiber diameter of 502 ± 150 nm, and the tensile strength, contact angle, porosity, water vapor permeability and water uptake ratio of CA/Gel nanofibers were around 2.83 ± 0.08 MPa, 58.07 ± 2.35°, 78.17 ± 1.04%, 11.23 ± 1.05 mg/cm2/hr, and 12.78 ± 0.32%, respectively, while these values for CA/Gel/Beri nanofibers were 2.69 ± 0.05 MPa, 56.93 ± 1°, 76.17 ± 0.76%, 10.17 ± 0.21 mg/cm2/hr, and 14.37 ± 0.42%, respectively. The antibacterial evaluations demonstrated that the dressings exhibited potent antibacterial activity. The collagen density of 88.8 ± 6.7% and the angiogenesis score of 19.8 ± 3.8 obtained in the animal studies indicate a proper wound healing. These findings implied that the incorporation of berberine did not compromise the physical properties of dressing, while improving the biological activities. In conclusion, our results indicated that the prepared mat is a proper wound dressing for DFU management and treatment.

1 October 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
AEArian Ehterami
Arian Ehterami
NMNaimeh Mahheidari
Naimeh Mahheidari
SFSaeed Farzamfar
Saeed Farzamfar
AVAhmad Vaez
Ahmad Vaez
HSHadi Samadian
Hadi Samadian
AGArash Goodarzi
Arash Goodarzi

1 June 2019 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
AEArian Ehterami
Arian Ehterami
MSMajid Salehi
Majid Salehi
SFSaeed Farzamfar
Saeed Farzamfar
HSHadi Samadian
Hadi Samadian
AVAhmad Vaez
Ahmad Vaez
HSHamed Sahrapeyma
Hamed Sahrapeyma

1 December 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
MNMahdi Naseri-Nosar
Mahdi Naseri-Nosar
SFSaeed Farzamfar
Saeed Farzamfar
HSHamed Sahrapeyma
Hamed Sahrapeyma
SGSadegh Ghorbani
Sadegh Ghorbani
FBFarshid Bastami
Farshid Bastami
MSMajid Salehi
Majid Salehi

21 August 2022 in Nanotheranostics
Verified
Journal Article
Open access
SMSareh Mosleh-Shirazi
Sareh Mosleh-Shirazi
MAMilad Abbasi
Milad Abbasi
MMMohammad Reza Moaddeli
Mohammad Reza Moaddeli
AVAhmad Vaez
Ahmad Vaez
MSMostafa Shafiee
Mostafa Shafiee
SHSaeid Hatam
Saeid Hatam
Over the last few years, progress has been made across the nanomedicine landscape, in particular, the invention of contemporary nanostructures for cancer diagnosis and overcoming complexities in the clinical treatment of cancerous tissues. Thanks to their small diameter and large surface-to-volume proportions, nanomaterials have special physicochemical properties that empower them to bind, absorb and transport high-efficiency substances, such as small molecular drugs, DNA, proteins, RNAs, and probes. They also have excellent durability, high carrier potential, the ability to integrate both hydrophobic and hydrophilic compounds, and compatibility with various transport routes, making them especially appealing over a wide range of oncology fields. This is also due to their configurable scale, structure, and surface properties. This review paper discusses how nanostructures can function as therapeutic vectors to enhance the therapeutic value of molecules; how nanomaterials can be used as medicinal products in gene therapy, photodynamics, and thermal treatment; and finally, the application of nanomaterials in the form of molecular imaging agents to diagnose and map tumor growth.

19 February 2018 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Closed access
HSHadi Samadian
Hadi Samadian
NMNaimeh Mahheidari
Naimeh Mahheidari
SFSaeed Farzamfar
Saeed Farzamfar
AVAhmad Vaez
Ahmad Vaez
AEArian Ehterami
Arian Ehterami
SGSadegh Ghorbani
Sadegh Ghorbani
The present study aimed to evaluate the efficacy of cellulose acetate/gelatin/nanohydroxyapatite (CA/Gel/nHA) nanocomposite mats as the wound dressing. The dressings were prepared with electrospinning of CA/Gel solutions containing 12.5, 25 and 50 mg nHA. The dressings were evaluated regarding their water uptake capacity, morphology, tensile strength, water vapour transmission rate, wettability and cellular response with L929 cell line. The results showed that the concentration of nHA had a direct correlation with porosity, water contact angle, water uptake, water vapor transmission rate and proliferation. In vivo studies showed that all dressings had higher wound closure percent than the sterile gauze, as the control. The highest wound closure value was achieved in the CA/Gel +25 mg nHA group, which showed 93.5 ± 1.6%. The histological and the histomorphometric examinations of the wounds revealed that the CA/Gel +25 mg nHA dressing had the greatest collagen synthesis, re-epithelialization, neovascularization and also the best cosmetic appearance. Based on our finding, it could be concluded the applicability of electrospun nanofibrous CA/Gel/nHA dressings for successful wound treatment.